Research Interests
cancer/oncogenesis
,
vaccines
Recent Publications
Stinchcombe T, Socinski MA, Moore DT, Gettinger SN, Decker RH, Petty WJ, Blackstock AW, Schwartz G, Lankford S, Morris DE.
Phase I/II trial of bevacizumab (B) and erlotinib (E) with induction (IND) and concurrent (CON) carboplatin (Cb)/paclitaxel (P) and 74 Gy of thoracic conformal radiotherapy (TCRT) in stage III non-small cell lung cancer (NSCLC) [abstract]. J Clin Oncol.
2011;
29(Suppl):abstr 7016.
Mamon HJ, Niedzwiecki D, Hollis D, Tan BR, Mayer RJ, Tepper JE, Goldberg RM, Blackstock AW, Fuchs CS.
A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : Cancer and Leukemia Group B (CALGB) 80003. Cancer.
2011;
117(12):2620-2628.
Yang X, Walton W, Cook DN, Hua X, Tilley S, Haskell CA, Horuk R, Blackstock AW, Kirby SL.
The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis. Am J Respir Cell Mol Biol.
2011;
45(1):127-135.
Attia A, Vern-Gross T, Garg PK, Garg S, Thomas A, Smith H, Monjazeb A, Blackstock AW.
The utility of 11C-choline positron emission tomography computerized tomography (PET-CT) for staging locally advanced esophageal cancer [abstract]. Int J Radiat Oncol Biol Phys.
2011;
81(2 Suppl):S314.
Monjazeb AM, Riedlinger G, Isom S, Aklilu M, Geisinger KR, Mishra G, Levine EA, Blackstock AW.
Radiotherapy for esophageal cancer: does dose affect outcomes? [abstract]. Int J Radiat Oncol Biol Phys.
2010;
78(3 Suppl):S307.
Lally BE, Geiger AM, Urbanic JJ, Butler JM, Wentworth S, Perry MC, Wilson LD, Horton JK, Detterbeck FC, Miller AA, Blackstock AW, et al.
Trends in the outcomes for patients with limited stage small cell lung cancer: an analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer.
2009;
64(2):226-231.
Blackstock AW, Aklilu M, Lovato J, Degrass L, Sommer J, Howerton R, Mishra G, Levine E, McQuellon R.
Aprepitant/5HT-3 antagonist (EMEND) for the prevention of chemoradiation-induced nausea and vomiting (CRINV) in patients receiving gemcitabine/5-FU-based chemoradiation and concurrent upper abdominal radiation for pancreatic cancer [abstract]. J Clin Oncol.
2009;
27(Suppl):e20661.
Socinski MA, Stinchcombe TE, Halle JS, Moore DT, Petty WJ, Blackstock AW, Gettinger SN, Decker RH, Khandani AH, Morris DE.
Incorporation of bevacizumab (B) and erlotinib (Er) with induction (I) and concurrent (C) carboplatin (Cb)/paclitaxel (P) and 74 Gy of thoracic radiotherapy in stage III non-small cell lung cancer (NSCLC) [abstract]. J Thorac Oncol.
2009;
4(9 Suppl 1):S372-S373.
Bogart JA, Hodgson L, Seagren SL, Blackstock AW, Wang X, Lenox R, Turrisi AT III, Reilly J, Gajra A, Vokes EE, et al.
Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. J Clin Oncol.
2009;
28(2):202-206.
Socinski MA, Stinchcombe TE, Halle JS, Moore DT, Petty WJ, Blackstock AW, Gettinger SN, Decker RH, Khandani AH, Morris DE.
Incorporation of bevacizumab (B) and erlotinib (Er) with induction (Ind) and concurrent (Conc) carboplatin (Cb)/paclitaxel (P) and 74 Gy of thoracic radiotherapy in stage III non-small cell lung cancer (NSCLC) [abstract]. J Clin Oncol.
2009;
27(15 Suppl):7528.
Socinski MA, Blackstock AW, Bogart JA, Wang X, Munley M, Rosenman J, Gu L, Masters GA, Sleeper A, Miller AA, et al.
Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. J Clin Oncol.
2008;
26(15):2457-2463.
Hampton CJ, Kearns WT, Urbanic JJ, McMullen KP, Blackstock AW, Hinson WH.
Impact of individualized target volumes on stereotactic body radiotherapy treatment planning (SBRT): volumetric analysis [abstract]. Int J Radiat Oncol Biol Phys.
2008;
72(1 Suppl):S617.
Hampton CJ, Kearns WT, Urbanic JJ, McMullen KP, Blackstock AW, Hinson WH.
Impact of individualized target volumes on stereotactic body radiotherapy treatment planning (SBRT): dosimetric analysis [abstract]. Int J Radiat Oncol Biol Phys.
2008;
72(1 Suppl):S625-S626.
Lally BE, Blackstock A, Buyyounouski MK, Feigenberg SJ, Scott WJ, Thomas CR, Konski AA.
The effect of race on combining surgery and radiation in locally advanced non-small cell lung cancer [abstract]. Int J Radiat Oncol Biol Phys.
2008;
72(1 Suppl):S42.
Urbanic JJ, McMullen KP, Stieber VW, Hinson WH, Kearns WT, Hampton CJ, Lovato JF, Livengood K, Rosdahl R, Blackstock AW.
A phase I/II dose-escalation/efficacy study, of single fraction stereotactic body radiotherapy (SF-SBRT) for metastatic cancer [abstract]. Int J Radiat Oncol Biol Phys.
2008;
72(1 Suppl):S140.
Socinski MA, Morris DE, Stinchcombe TE, Halle JS, Moore DT, Tynan MT, Siegel MA, Petty WJ, Blackstock AW, Khandani AH, et al.
Incorporation of bevacizumab (B) and erlotinib (Er) with induction (I) and concurrent (C) carboplatin (Cb)/paclitaxel (P) and 74 Gy of thoracic radiotherapy in stage III non-small cell lung cancer (NSCLC) [abstract]. J Clin Oncol.
2008;
26(15 Suppl):401s.
Gill S, Blackstock AW, Goldberg RM.
Colorectal cancer. Mayo Clin Proc.
2007;
82(1):114-129.
Blackstock AW.
Cancer of the esophagus. In: Gunderson LL, Tepper JE, eds. Clinical radiation oncology. 2nd ed.
Philadelphia: Elsevier Churchill Livingstone;
2007:
951-972.
Easler J, Fennimore B, Farmer M, Yacoub J, Geisinger K, Aklilu M, Blackstock W, Case D, Levine E, Mishra G.
Molecular profiling with MIB-1 correlates with microscopic evidence of residual disease in patients undergoing neoadjuvant therapy for esophageal cancer (EC) [abstract]. Gastroenterology.
2007;
132(4 Suppl 2):A854.
Blackstock A, Petty J, Oaks T, Porosnicu M, Clark H, Lovato J, Miller A.
Gefitinig (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage III NSCLC: a phase I study [abstract]. J Clin Oncol.
2007;
25(18 Suppl):Abstr18165.
Hinson WH, Kearns WT, Hampton CJ, Urbanic JJ, Blackstock AW, McMullen KP, Stieber VW.
SBRT simulations using PET/CT: radiation safety concerns [abstract]. Med Phys.
2007;
34(6):2488.
Lally BE, Detterbeck FC, Geiger AM, Thomas CR Jr, Machtay M, Miller AA, Oaks TE, Petty WJ, Robbins ME, Blackstock AW, et al.
The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database. Cancer.
2007;
110(4):911-917.
Blackstock AW, Jensen CA, Petty WJ, Oaks T, Porosnicu M, Clark H, Lovato JF, Miller A.
Gefitinib (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage III NSCLC: a phase I study [abstract]. Int J Radiat Oncol Biol Phys.
2007;
69(3 Suppl):S476.
Kim C, Farmer MR, Yacoub J, Monjazeb A, Levine EA, Aklilu M, Geinsinger [sic] KR [Geisinger KR], Mishra G, Melin S, Blackstock AW.
Tri-modality therapy for esophageal cancer: mucinous histology is associated with decreased pathologic response rates to neoadjuvant chemoradiation therapy [abstract]. Int J Radiat Oncol Biol Phys.
2007;
69(3 Suppl):S267.
Lally BE, Shaw EG, Knisely JPS, Blackstock AW, Robbins MC, Geiger AM.
Low grade gliomas: demographic, tumor and treatment factors associated with survival [abstract]. Int J Radiat Oncol Biol Phys.
2007;
69(3 Suppl):S185.
Monjazeb AM, Farmer MR, Mattern M, Mebea A, Levine EA, Geisinger KR, Mishra G, Melin S, Blackstock AW.
Patterns of failure for esophageal cancer patients optimally staged with 18-F-FDG-PET and observed after chemo-radiotherapy [abstract]. Int J Radiat Oncol Biol Phys.
2007;
69(3 Suppl):S274.
Blackstock AW, Mornex F, Partensky C, Descos L, Case LD, Melin SA, Levine EA, Mishra G, Limentani SA, Kachnic LA, et al.
Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. Br J Cancer.
2006;
95(3):260-265.
Blackstock AW, Socinski MA, Bogart J, Gu L, Wang X, Green M, Vokes EE.
Induction (Ind) plus concurrent (Con) chemotherapy with high-dose (74 Gy) 3-dimensional (3-D) thoracic radiotherapy (TRT) in stage III non-small cell lung cancer (NSCLC): preliminary report of Cancer and Leukemia Group B (CALGB) 30105 [abstract]. J Clin Oncol.
2006;
24(18 Suppl Pt I):374s.
Butler JM, Lally BE, D'Agostino R, Urbanic JJ, Wentworth S, Paskett E, Blackstock AW.
Impact of race and marital status on survival and stage at presentation for patients with colorectal cancer: an analysis of data from the Surveillance, Epidemiology, and End-Results (SEER) program [abstract]. Int J Radiat Oncol Biol Phys.
2006;
66(3 Suppl):S70.
Farmer MR, Yacoub J, Aklilu M, Levine EA, Geisinger K, Mishra G, Melin S, Blackstock AW.
Tri-modality therapy for esophageal cancer: hemoglobin levels are prognostic for survival but do not predict response to radiochemotherapy [abstract]. Int J Radiat Oncol Biol Phys.
2006;
66(3 Suppl):S269.
Lally BE, Urbanic JJ, Butler JM, Wentworth S, Thomas CR, Blackstock A.
Outcomes of patients with limited-stage small cell lung cancer treated with radiotherapy: analysis of data from the Surveillance, Epidemiology, and End-Results (SEER) program [abstract]. Int J Radiat Oncol Biol Phys.
2006;
66(3 Suppl):S87.
Urbanic JJ, Hinson WH, Stieber VW, Butler JM, Kearns WT, Hampton CJ, Blackstock AW.
Heterogeneity corrections in stereotactic body radiotherapy (54 Gy in 3 fractions) for lung tumors significantly alter delivered dose [abstract]. Int J Radiat Oncol Biol Phys.
2006;
66(3 Suppl):S479-S480.
Wentworth S, Lally B, Butler J, Urbanic J, Blackstock A.
Impact of race on survival and radiotherapy use in patients with non-metastatic rectal cancer: analysis of data from the Surveillance, Epidemiology and End-Results (SEER) program [abstract]. Int J Radiat Oncol Biol Phys.
2006;
66(3 Suppl):S68.
Lally BE, Butler J, Mishra G, Paskett ED, Blackstock AW.
The impact of ethnicity on survival for patients with pancreatic cancer: a SEER analysis [abstract]. In: 2006 Gastrointestinal Cancers Symposium Abstracts; 2006 Jan 26-28; San Fransciso (CA).
2006;
():Abstr 100.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.